Search research articles
Contact Us
Filters
Showing results (231-240 of 328) with videos related to
Page
of 33
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Jesús Garcia Castro, Lídia Vaqué-Alcázar, Lawren VandeVrede, et al.
Nature Medicine
|
May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Jeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
JAMA Network Open
|
April 29, 2022
Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
Ignacio Illán-Gala, Salvatore Nigro, Lawren VandeVrede, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 20, 2020
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, et al.
JAMA Neurology
|
June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
Rik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2025
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance
Igor Prufer Q C Araujo, Tara Ellingson, Nicholas U Schwartz, et al.
Molecular Neurodegeneration
|
May 25, 2016
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
JAMA Neurology
|
April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
Breton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
JAMA Network Open
|
October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants
Adam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 328) with videos related to
Sort By:
Page
of 33
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Jesús Garcia Castro, Lídia Vaqué-Alcázar, Lawren VandeVrede, et al.
Nature Medicine
|
May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Jeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
JAMA Network Open
|
April 29, 2022
Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
Ignacio Illán-Gala, Salvatore Nigro, Lawren VandeVrede, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 20, 2020
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, et al.
JAMA Neurology
|
June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
Rik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2025
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance
Igor Prufer Q C Araujo, Tara Ellingson, Nicholas U Schwartz, et al.
Molecular Neurodegeneration
|
May 25, 2016
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
JAMA Neurology
|
April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
Breton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
JAMA Network Open
|
October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants
Adam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Page
of 33